1 year ago Tags API Holdings NCD issue PharmEasy’s Debt Spiral: Why India’s Unicorn Is Betting Big on Thyrocare Again India’s health-tech poster child PharmEasy is once again leaning on its diagnostics arm Thyrocare to stay afloat. Its parent company,
